{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T07:18:49Z","timestamp":1785568729988,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T00:00:00Z","timestamp":1628121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2321-B-075-003"],"award-info":[{"award-number":["108-2321-B-075-003"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["109-2321-B-075-001"],"award-info":[{"award-number":["109-2321-B-075-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V108C-145"],"award-info":[{"award-number":["V108C-145"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"publisher","award":["V109C-135"],"award-info":[{"award-number":["V109C-135"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Studies suggest that enzyme-replacement therapy (ERT) is crucial to the survival of patients with infantile-onset Pompe disease (IOPD). Hearing impairment (HI) is one of the clinical sequelae observed in long-term survivors. However, the benefits of early ERT for hearing outcomes have not yet been reported. This study aimed to investigate the impact of early ERT on IOPD patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective longitudinal study recruited IOPD patients who were referred by newborn screening for confirmatory diagnosis based on our rapid diagnostic criteria and received early ERT treatment between January 1, 2010, and January 31, 2018. The hearing test battery included a tympanogram, otoacoustic emission, auditory brainstem evoked response (ABR), pure-tone audiometry or conditioned play audiometry.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Nineteen patients with IOPD were identified, 6 of whom had hearing impairment (HI); 1 had conductive HI, 2 had sensorineural HI (one had bilateral mild HI and one had mild HI in a single ear) and 1 had moderate mixed-type HI. Two patients failed the newborn screening test and had mild HI in the ABR. The mean age of the initial time to ERT was 11.05\u2009\u00b1\u20094.31\u00a0days, and the HI rate was 31.6% (6\/19).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study is the largest cohort to show the characteristic hearing outcomes of IOPD patients after ERT. Early ERT within 2\u00a0weeks after birth may contribute to better hearing outcomes. Clinicians should be vigilant in testing for the hearing issues associated with IOPD and should intervene early if any HI is detected.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-021-01817-1","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T07:02:51Z","timestamp":1628146971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hearing characteristics of infantile-onset Pompe disease after early enzyme-replacement therapy"],"prefix":"10.1186","volume":"16","author":[{"given":"Chien-Yu","family":"Hsueh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chii-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chen","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Sheng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Lien","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Liang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1995-5854","authenticated-orcid":false,"given":"Yen-Fu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dau-Ming","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,5]]},"reference":[{"issue":"1","key":"1817_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1042\/bj0860011","volume":"86","author":"HG Hers","year":"1963","unstructured":"Hers HG. \u03b1-Glucosidase deficiency in generalized glycogen-storage disease (Pompe\u2019s disease). Biochem J. 1963;86(1):11\u20136.","journal-title":"Biochem J"},{"key":"1817_CR2","first-page":"3389","volume-title":"The metabolic and molecular bases of inherited disease","author":"R Hirschhorn","year":"2001","unstructured":"Hirschhorn R, Reuser AJJ, et al. Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency. In: Beaudet A, Scriver C, Sly W, et al., editors. The metabolic and molecular bases of inherited disease. New York: McGraw Hill; 2001. p. 3389\u2013420."},{"issue":"5 Suppl","key":"1817_CR3","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","volume":"144","author":"PS Kishnani","year":"2004","unstructured":"Kishnani PS, Howell RR. Pompe disease in infants and children. J Pediatr. 2004;144(5 Suppl):S35-43. https:\/\/doi.org\/10.1016\/j.jpeds.2004.01.053.","journal-title":"J Pediatr"},{"issue":"1","key":"1817_CR4","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1542\/peds.2007-2222","volume":"122","author":"Y-H Chien","year":"2008","unstructured":"Chien Y-H, Chiang S-C, Zhang XK, et al. Early detection of Pompe disease by newborn screening is feasible: results from the Taiwan screening program. Pediatrics. 2008;122(1):e39-45. https:\/\/doi.org\/10.1542\/peds.2007-2222.","journal-title":"Pediatrics"},{"issue":"1","key":"1817_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/bf01799482","volume":"10","author":"CY Lin","year":"1987","unstructured":"Lin CY, Hwang B, Hsiao KJ, Jin YR. Pompe\u2019s disease in Chinese and prenatal diagnosis by determination of alpha-glucosidase activity. J Inherit Metab Dis. 1987;10(1):11\u20137. https:\/\/doi.org\/10.1007\/bf01799482.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1817_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/(sici)1096-8628(19980827)79:1<69::aid-ajmg16>3.0.co;2-k","volume":"79","author":"F Martiniuk","year":"1998","unstructured":"Martiniuk F, Chen A, Mack A, et al. Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet. 1998;79(1):69\u201372. https:\/\/doi.org\/10.1002\/(sici)1096-8628(19980827)79:1%3c69::aid-ajmg16%3e3.0.co;2-k.","journal-title":"Am J Med Genet"},{"issue":"6","key":"1817_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","volume":"7","author":"MG Ausems","year":"1999","unstructured":"Ausems MG, Verbiest J, Hermans MP, et al. Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet EJHG. 1999;7(6):713\u20136. https:\/\/doi.org\/10.1038\/sj.ejhg.5200367.","journal-title":"Eur J Hum Genet EJHG"},{"issue":"1\u20132","key":"1817_CR8","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s004399900075","volume":"105","author":"BJ Poorthuis","year":"1999","unstructured":"Poorthuis BJ, Wevers RA, Kleijer WJ, et al. The frequency of lysosomal storage diseases in The Netherlands. Hum Genet. 1999;105(1\u20132):151\u20136. https:\/\/doi.org\/10.1007\/s004399900075.","journal-title":"Hum Genet"},{"issue":"3","key":"1817_CR9","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281(3):249\u201354. https:\/\/doi.org\/10.1001\/jama.281.3.249.","journal-title":"JAMA"},{"issue":"2","key":"1817_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/sj.ejhg.5201044","volume":"12","author":"R Pinto","year":"2004","unstructured":"Pinto R, Caseiro C, Lemos M, et al. Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet EJHG. 2004;12(2):87\u201392. https:\/\/doi.org\/10.1038\/sj.ejhg.5201044.","journal-title":"Eur J Hum Genet EJHG"},{"issue":"2","key":"1817_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s10545-011-9396-3","volume":"35","author":"NAME van der Beek","year":"2012","unstructured":"van der Beek NAME, Verschuure H, Reuser AJJ, van der Ploeg AT, van Doorn PA, Poublon RML. Hearing in adults with Pompe disease. J Inherit Metab Dis. 2012;35(2):335\u201341. https:\/\/doi.org\/10.1007\/s10545-011-9396-3.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"1817_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.nbd.2003.12.018","volume":"16","author":"JHJ Kamphoven","year":"2004","unstructured":"Kamphoven JHJ, de Ruiter MM, Winkel LPF, et al. Hearing loss in infantile Pompe\u2019s disease and determination of underlying pathology in the knockout mouse. Neurobiol Dis. 2004;16(1):14\u201320. https:\/\/doi.org\/10.1016\/j.nbd.2003.12.018.","journal-title":"Neurobiol Dis"},{"issue":"5","key":"1817_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","volume":"148","author":"PS Kishnani","year":"2006","unstructured":"Kishnani PS, Hwu W-L, Mandel H, et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr. 2006;148(5):671\u20136. https:\/\/doi.org\/10.1016\/j.jpeds.2005.11.033.","journal-title":"J Pediatr"},{"issue":"1","key":"1817_CR14","doi-asserted-by":"publisher","first-page":"13473","DOI":"10.1038\/s41598-017-14063-y","volume":"7","author":"T Yoshida","year":"2017","unstructured":"Yoshida T, Awaya T, Jonouchi T, et al. A skeletal muscle model of infantile-onset Pompe disease with patient-specific iPS cells. Sci Rep. 2017;7(1):13473. https:\/\/doi.org\/10.1038\/s41598-017-14063-y.","journal-title":"Sci Rep"},{"issue":"4","key":"1817_CR15","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jpeds.2014.10.068","volume":"166","author":"Y-H Chien","year":"2015","unstructured":"Chien Y-H, Lee N-C, Chen C-A, et al. Long-term prognosis of patients with infantile-onset Pompe disease diagnosed by Newborn screening and treated since birth. J Pediatr. 2015;166(4):985-991.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2014.10.068.","journal-title":"J Pediatr"},{"issue":"2","key":"1817_CR16","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HMP van den Hout","year":"2003","unstructured":"van den Hout HMP, Hop W, van Diggelen OP, et al. The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics. 2003;112(2):332\u201340. https:\/\/doi.org\/10.1542\/peds.112.2.332.","journal-title":"Pediatrics"},{"issue":"2","key":"1817_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M, et al. Recombinant human acid \u03b1-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology. 2007;68(2):99\u2013109. https:\/\/doi.org\/10.1212\/01.wnl.0000251268.41188.04.","journal-title":"Neurology"},{"issue":"2","key":"1817_CR18","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1067\/mpd.2000.107112","volume":"137","author":"AE Slonim","year":"2000","unstructured":"Slonim AE, Bulone L, Ritz S, Goldberg T, Chen A, Martiniuk F. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr. 2000;137(2):283\u20135. https:\/\/doi.org\/10.1067\/mpd.2000.107112.","journal-title":"J Pediatr"},{"key":"1817_CR19","doi-asserted-by":"publisher","unstructured":"ACMG Work Group on Management of Pompe Disease, Kishnani PS, Steiner RD, et al. Pompe disease diagnosis and management guideline. Genet Med Off J Am Coll Med Genet. 2006;8(5):267\u2013288. https:\/\/doi.org\/10.1097\/01.gim.0000218152.87434.f3","DOI":"10.1097\/01.gim.0000218152.87434.f3"},{"key":"1817_CR20","doi-asserted-by":"crossref","unstructured":"Ebbink BJ, Aarsen FK, van Gelder CM. Cognitive outcome of patients with classic infantile Pompe disease receiving enzyme therapy. Published online 2012:7.","DOI":"10.1186\/1471-2474-14-S2-P14"},{"issue":"6","key":"1817_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s10545-010-9209-0","volume":"33","author":"M Rohrbach","year":"2010","unstructured":"Rohrbach M, Klein A, K\u00f6hli-Wiesner A, et al. CRIM-negative infantile Pompe disease: 42-month treatment outcome. J Inherit Metab Dis. 2010;33(6):751\u20137. https:\/\/doi.org\/10.1007\/s10545-010-9209-0.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1817_CR22","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s10545-010-9144-0","volume":"33","author":"CI van Capelle","year":"2010","unstructured":"van Capelle CI, Goedegebure A, Homans NC, Hoeve HLJ, Reuser AJ, van der Ploeg AT. Hearing loss in Pompe disease revisited: results from a study of 24 children. J Inherit Metab Dis. 2010;33(5):597\u2013602. https:\/\/doi.org\/10.1007\/s10545-010-9144-0.","journal-title":"J Inherit Metab Dis"},{"key":"1817_CR23","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/8904_2014_392","volume":"20","author":"A Hahn","year":"2015","unstructured":"Hahn A, Praetorius S, Karabul N, et al. Outcome of patients with classical infantile pompe disease receiving enzyme replacement therapy in Germany. JIMD Rep. 2015;20:65\u201375. https:\/\/doi.org\/10.1007\/8904_2014_392.","journal-title":"JIMD Rep"},{"issue":"1","key":"1817_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ajmg.a.36197","volume":"164A","author":"C-F Yang","year":"2014","unstructured":"Yang C-F, Liu H-C, Hsu T-R, et al. A large-scale nationwide newborn screening program for Pompe disease in Taiwan: towards effective diagnosis and treatment. Am J Med Genet A. 2014;164A(1):54\u201361. https:\/\/doi.org\/10.1002\/ajmg.a.36197.","journal-title":"Am J Med Genet A"},{"issue":"174\u2013180","key":"1817_CR25","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jpeds.2015.10.078","volume":"169","author":"C-F Yang","year":"2016","unstructured":"Yang C-F, Yang CC, Liao H-C, et al. Very early treatment for infantile-onset Pompe disease contributes to better outcomes. J Pediatr. 2016;169(174\u2013180):e1. https:\/\/doi.org\/10.1016\/j.jpeds.2015.10.078.","journal-title":"J Pediatr"},{"issue":"7","key":"1817_CR26","first-page":"493","volume":"23","author":"JG Clark","year":"1981","unstructured":"Clark JG. Uses and abuses of hearing loss classification. ASHA. 1981;23(7):493\u2013500.","journal-title":"ASHA"},{"issue":"2","key":"1817_CR27","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1597\/06-078.1","volume":"45","author":"N Viswanathan","year":"2008","unstructured":"Viswanathan N, Vidler M, Richard B. Hearing thresholds in newborns with a cleft palate assessed by auditory brain stem response. Cleft Palate-Craniofacial J Off Publ Am Cleft Palate Craniofacial Assoc. 2008;45(2):187\u201392. https:\/\/doi.org\/10.1597\/06-078.1.","journal-title":"Cleft Palate-Craniofacial J Off Publ Am Cleft Palate Craniofacial Assoc"},{"issue":"4","key":"1817_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1001\/archotol.1970.04310040005002","volume":"92","author":"J Jerger","year":"1970","unstructured":"Jerger J. Clinical experience with impedance audiometry. Arch Otolaryngol Chic Ill 1960. 1970;92(4):311\u201324. https:\/\/doi.org\/10.1001\/archotol.1970.04310040005002.","journal-title":"Arch Otolaryngol Chic Ill 1960"},{"issue":"3","key":"1817_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/bf00687878","volume":"23","author":"JJ Martin","year":"1973","unstructured":"Martin JJ, de Barsy T, van Hoof F, Palladini G. Pompe\u2019s disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle. Acta Neuropathol (Berl). 1973;23(3):229\u201344. https:\/\/doi.org\/10.1007\/bf00687878.","journal-title":"Acta Neuropathol (Berl)"},{"key":"1817_CR30","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3389\/fimmu.2019.00416","volume":"10","author":"X Xu","year":"2019","unstructured":"Xu X, Negandhi J, Min W, et al. Early enzyme replacement therapy improves hearing and immune defects in adenosine deaminase deficient-mice. Front Immunol. 2019;10:416. https:\/\/doi.org\/10.3389\/fimmu.2019.00416.","journal-title":"Front Immunol"},{"issue":"3","key":"1817_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ejpn.2016.12.004","volume":"21","author":"Y-T Zeng","year":"2017","unstructured":"Zeng Y-T, Hwu W-L, Torng P-C, et al. Longitudinal follow-up to evaluate speech disorders in early-treated patients with infantile-onset Pompe disease. Eur J Paediatr Neurol. 2017;21(3):485\u201393. https:\/\/doi.org\/10.1016\/j.ejpn.2016.12.004.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"1817_CR32","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10545-011-9404-7","volume":"35","author":"CM van Gelder","year":"2012","unstructured":"van Gelder CM, van Capelle CI, Ebbink BJ, et al. Facial-muscle weakness, speech disorders and dysphagia are common in patients with classic infantile Pompe disease treated with enzyme therapy. J Inherit Metab Dis. 2012;35(3):505\u201311. https:\/\/doi.org\/10.1007\/s10545-011-9404-7.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"1817_CR33","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10545-011-9320-x","volume":"34","author":"TA Kanters","year":"2011","unstructured":"Kanters TA, Hagemans MLC, van der Beek NAME, Rutten FFH, van der Ploeg AT, Hakkaart L. Burden of illness of Pompe disease in patients only receiving supportive care. J Inherit Metab Dis. 2011;34(5):1045\u201352. https:\/\/doi.org\/10.1007\/s10545-011-9320-x.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"1817_CR34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ymgme.2017.04.014","volume":"121","author":"GA Spiridigliozzi","year":"2017","unstructured":"Spiridigliozzi GA, Keeling LA, Stefanescu M, Li C, Austin S, Kishnani PS. Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up. Mol Genet Metab. 2017;121(2):127\u201337. https:\/\/doi.org\/10.1016\/j.ymgme.2017.04.014.","journal-title":"Mol Genet Metab"},{"issue":"14","key":"1817_CR35","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1177\/0883073816665549","volume":"31","author":"C-J Lai","year":"2016","unstructured":"Lai C-J, Hsu T-R, Yang C-F, Chen S-J, Chuang Y-C, Niu D-M. Cognitive development in infantile-onset Pompe disease under very early enzyme replacement therapy. J Child Neurol. 2016;31(14):1617\u201321. https:\/\/doi.org\/10.1177\/0883073816665549.","journal-title":"J Child Neurol"},{"issue":"2 Pt 1","key":"1817_CR36","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/000348948109000208","volume":"90","author":"SK Juhn","year":"1981","unstructured":"Juhn SK, Rybak LP, Prado S. Nature of blood-labyrinth barrier in experimental conditions. Ann Otol Rhinol Laryngol. 1981;90(2 Pt 1):135\u201341. https:\/\/doi.org\/10.1177\/000348948109000208.","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"6","key":"1817_CR37","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/s0196-0709(82)80016-1","volume":"3","author":"SK Juhn","year":"1982","unstructured":"Juhn SK, Rybak LP, Fowlks WL. Transport characteristics of the blood\u2013perilymph barrier. Am J Otolaryngol. 1982;3(6):392\u20136. https:\/\/doi.org\/10.1016\/s0196-0709(82)80016-1.","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"1817_CR38","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.heares.2011.08.006","volume":"282","author":"X Shi","year":"2011","unstructured":"Shi X. Physiopathology of the cochlear microcirculation. Hear Res. 2011;282(1):10\u201324. https:\/\/doi.org\/10.1016\/j.heares.2011.08.006.","journal-title":"Hear Res"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01817-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-021-01817-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-021-01817-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T07:07:12Z","timestamp":1628147232000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-021-01817-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,5]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1817"],"URL":"https:\/\/doi.org\/10.1186\/s13023-021-01817-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,5]]},"assertion":[{"value":"26 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Institutional Review Board (IRB) of the Taipei Veterans General Hospital approved this study (IRB No.2020-11-004AC). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}